Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–6 of 6 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07482176
- Conditions
- Blindness, Eye Diseases, Neovascular Age-related Macular Degeneration (nAMD), +7 more
- Locations
-
- Adverum Clinical Site 245 Mesa, Arizona, United States
- Adverum Clinical Site 126 Phoenix, Arizona, United States
- Adverum Clinical Site 178 Phoenix, Arizona, United States
- Adverum Clinical Site 223 Phoenix, Arizona, United States
Enrolling by Invitation
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
NCT05210803
- Conditions
- AMD, Gene Therapy, Neovascular Age-related Macular Degeneration (nAMD), +3 more
- Locations
-
- Retinal Research Institute, LLC Phoenix, Arizona, United States
- California Retina Consultants Bakersfield, California, United States
- Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
- Northern California Retina Vitreous Associates Medical Group Inc Mountain View, California, United States
NCT06704009
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +3 more
- Locations
-
- Elman Retina Group Rosedale, Maryland, United States
- Duke Eye Center Durham, North Carolina, United States
- Erie Retina Research Erie, Pennsylvania, United States
- Texas Retina Associates Dallas, Texas, United States
Completed
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
NCT00804934
- Conditions
- Wet AMD
- Locations
-
- Retina Institute of Hawaii Honolulu, Hawaii, United States
Active, Not Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
NCT06856577
- Conditions
- Blindness, Eye Diseases, Neovascular Age-related Macular Degeneration (nAMD), +7 more
- Locations
-
- Adverum Clinical Site 223 Gilbert, Arizona, United States
- Adverum Clinical Site 178 Phoenix, Arizona, United States
- Adverum Clinical Site 126 Phoenix, Arizona, United States
- Adverum Clinical Site 229 Scottsdale, Arizona, United States
Active, Not Recruiting
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
NCT04704921
- Conditions
- AMD, CNV, Choroid Diseases, +18 more
- Locations
-
- Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
- Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
- University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
- Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States